INS and breast carcinoma: The serum insulin and glucose values were used to calculate the homeostasis model assessment (HOMA)-insulin resistance index, which provides a closer reflection of the insulin resistance as indicated by the euglycemic-hyperinsulinemic clamp method than the fasting plasma insulin alone [64], and this also showed a positive association with postmenopausal breast cancer risk.